Frontdoor, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Frontdoor, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.09B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.84B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.78B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.66B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.60B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $1.47B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $1.37B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.26B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $1.16B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $1.02B | Feb 28, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.09B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.84B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.78B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.66B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.60B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $1.47B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $1.37B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.26B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $1.16B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $1.02B | Feb 28, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.16B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $991.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $885.00M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $710.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $784.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $716.00M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $678.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $572.00M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $567.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $494.00M | Feb 28, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $255.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $235.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $171.00M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $71.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $128.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $112.00M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $153.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $125.00M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $160.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $124.00M | Feb 28, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $669.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $612.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $581.00M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $521.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $511.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $467.00M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $392.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $338.00M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $312.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $286.00M | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $416.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $270.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $202.00M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $142.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $185.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $207.00M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $200.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $189.00M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $194.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $155.00M | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $39.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $32.00M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $40.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $31.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $32.00M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $22.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $27.00M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $15.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $11.00M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.14B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.11B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.09B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.08B | Feb 27, 2025 |
| FY2022 | Dec 31, 2021 | $1.07B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $1.41B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.25B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $1.04B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $1.42B | Feb 28, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $1.39B | Feb 28, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $242.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $239.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $136.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | $61.00M | Feb 26, 2026 |
| FY2024 | Dec 31, 2021 | $2.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2020 | ($61.00M) | Feb 28, 2024 |
| FY2022 | Dec 31, 2019 | ($179.00M) | Mar 1, 2023 |
| FY2021 | Dec 31, 2018 | ($344.00M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $661.00M | Feb 23, 2021 |
| FY2019 | Dec 31, 2016 | $560.00M | Feb 28, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $959.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $967.00M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $503.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $503.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $512.00M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $512.00M | Feb 25, 2022 |
| FY2021 | Dec 31, 2019 | $501.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $476.00M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $476.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $471.00M | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $785.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $530.00M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $296.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $124.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $53.00M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | ($75.00M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | ($188.00M) | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | ($336.00M) | Feb 28, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $566.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $421.00M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $325.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $292.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $262.00M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $597.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $428.00M | Feb 23, 2021 |
| FY2020 | Dec 31, 2018 | $296.00M | Feb 23, 2021 |
| FY2020 | Dec 31, 2017 | $282.00M | Feb 23, 2021 |
| FY2019 | Dec 31, 2016 | $168.00M | Feb 28, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.17B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.20B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $593.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $609.00M | Feb 28, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 28, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 28, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 70.96M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 75.31M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 78.38M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 81.52M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 83.23M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 85.48M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 85.31M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | 84.55M | Feb 28, 2020 |
| FY2019 | Oct 1, 2018 | 84.52M | Feb 28, 2020 |